Factors associated with the development of breast cancer-related lymphedema after whole-breast irradiation

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 4, 2012, Pages 1095-1100

  Shah, Chirag ^a   Wilkinson, John Ben ^a   Baschnagel, Andrew ^a   Ghilezan, Mihai ^a   Riutta, Justin ^a,b   Dekhne, Nayana ^a,b   Balaraman, Savitha ^a,b   Mitchell, Christina ^a   Wallace, Michelle ^a   Vicini, Frank ^a,b  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Breast cancer related lymphedema; Chemotherapy; Lymphedema; Predictors; Whole breast irradiation

Indexed keywords

ADJUVANT CHEMOTHERAPY; BREAST CANCER; BREAST-CONSERVING THERAPY; CLINICAL ASSESSMENTS; LYMPH NODE; LYMPHEDEMA; NODAL STATUS; PREDICTORS; WHOLE-BREAST IRRADIATION;

CHEMOTHERAPY; DISEASES; IRRADIATION; PATHOLOGY; RADIATION;

PATIENT TREATMENT;

ADULT; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RISK; CARCINOGENESIS; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; IRRADIATION; LYMPHEDEMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ACTUARIAL ANALYSIS; ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHEDEMA; MIDDLE AGED; NEOPLASM GRADING; RADIOTHERAPY, ADJUVANT; RISK; TUMOR BURDEN;

EID: 84862655611     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.09.058     Document Type: Article

References (18)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
2. Gartner R, Jensen MB, Kronborg L, et al. Self-reported arm-lymphedema and functional impairment after breast cancer treatment - A nationwide study of prevalence and associated factors. The Breast 2010;19:506-515.
3. Coen JJ, Taghian AG, Kachnic LA, et al. Risk of lymphedema after regional nodal irradiation with breast conservation therapy. Int J Radiat Oncol Biol Phys 2003;55:1209-1215.
4. Hayes SB, Freedman GM, Li T, et al. Does axillary boost increase lymphedema compared with supraclavicular alone after breast conservation? Int J Radiat Oncol Biol Phys 2008;72:1449-1455.
5. Redon CE, Dickey JS, Nakamura AJ, et al. Tumors induce complex DNA damage in distant proliferative tissues in vivo. Proc Natl Acad Sci U S A 2010;107:17992-17997.
6. Santini D, Fratto ME, Vincenzi B, et al. Bisphosphonate effects in cancer and inflammatory diseases: In vitro and in vivo modulation of cytokine activities. BioDrugs 2004;18:269-278.
7. Ahmed RL, Schmitz KH, Prizment AE, Folsom AR. Risk factors for lymphedema in breast cancer survivors, the Iowa Women's Health Study. Breast Cancer Res Treat. 2011 Jun 15 [Epub ahead of print].
8. Ashikaga T, Krag DN, Land SR, et al. Morbidity results from the NSABP-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol 2010;102:111-118.
9. Wernicke AG, Goodman RL, Turner BC, et al. A 10-year follow-up of treatment outcomes in patients with early stage breast cancer and clinically negative axillary nodes treated with tangential breast irradiation following sentinel lymph node dissection or axillary clearance. Breast Cancer Res Treat 2011;125:893-902.
10. Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs. no axillary dissection in women with invasive breast cancer and sentinel node metastasis:Arandomized clinical trial. JAMA2011;305:569-575.
11. Lucci A, McCall LM, Beitsch PD, et al. Surgical complications associated with sentinel lymph node dissection (SLND) Plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 2007; 25:3657-3663.
12. Deutsch M, Land S, Begovic M, et al. The incidence of arm edema in women with breast cancer randomized on the National Surgical Adjuvant Breast and Bowel Project Study B-04 to radical mastectomy versus total mastectomy and radiotherapy versus total mastectomy alone. Int J Radiat Oncol Biol Phys 2008;79:1020-1024.
13. Kwan ML, Darbinian J, Schmitz KH, et al. Risk factors for lymphedema in a prospective breast cancer study: The Pathways Study. Arch Surg 2010;145:1055-1063.
14. Hinrichs CS, Watroba NL, Rezaishiraz H, et al. Lymphedema secondary to postmastectomy radiation: Incidence and risk factors. Ann Surg Oncol 2004;11:573-580.
15. Cornish BH, Chapman M, Hirst C, et al. Early diagnosis of lymphedema using multiple frequency bioimpedance. Lymphology 2001;34:2-11.
16. Gjorup C, Zerahn B, Hendel HW. Assessment of volume measurement of breast cancer-related lymphedema by three methods: Circumference measurement, water displacement, and dual energy x-ray absorptiometry. Lymphat Res Biol 2010;8:111-119.
17. Stout Gergich NL, Pfalzer LA, McGarvey C, et al. Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer 2008;112:2809-2819.
18. Laco F, Grant MH, Flint DJ, Black RA. Cellular trans-differentiation and morphogenesis toward the lymphatic lineage in regenerative medicine. Stem Cells Dev 2011;20:181-195.